Table 1 Patients’ demographic and clinical characteristics
| Â | Group A | Group B |
|---|---|---|
n = 103 | n = 51 | |
Mean age (years) | 41.6 ± 12.9 | 45.2 ± 13.9 |
(range 19–77) | (range 18–85) | |
Sex | Â | Â |
- Male | 30 (29.1%) | 12 (23.5%) |
- Female | 73 (70.9%) | 39 (76.5%) |
Ethnic background | Â | Â |
- European | 99 (96.1%) | 50 (98%) |
- African | 4 (3.9%) | 1 (2%) |
Education level | Â | Â |
- Level 1 | 30 (29.1%) | 19 (37.3%) |
- Level 2 | 73 (70.9%) | 32 (62.8%) |
Residence | Â | Â |
- Rural | 55 (53.4%) | 30 (58.8%) |
- Urban | 48 (46.6%) | 21 (31.2%) |
Indication(s) for H. pylori eradication | Â | Â |
- Non-ulcer dyspepsia | 63 (61.2%) | 34 (66.7%) |
- Iron-deficient anemia | 25 (24.3%) | 7 (13.7%) |
- GERD/Chronic therapy with PPI | 24 (23.3%) | 17 (33.3%) |
- First-degree relatives with gastric cancer | 14 (13.6%) | 7 (13.7%) |
- Peptic ulcer | 9 (8.7%) | 4 (7.8%) |
BMI (Kg/m2) | 24.6 ± 4.2 | 25 ± 4 |
|  | (range 17.1–37.8) | (range 17.1–33.8) |
Alcohol consumption | 21 (20.4%) | 10 (19.6%) |
Smoking | 13 (12.6%) | 11 (21.6%) |
Olive oil consumption ≥1 dl/week | 53 (51.5%) | 27 (52.9%) |
History of frequent infections | 20 (19.4%) | 13 (25.5%) |
Antibiotic consumption in the last 12Â months | 28 (27.2%) | 40 (78.4%) |
Family history of gastric diseases | 49 (47.6%) | 29 (56.9%) |